Pediatric HIV in the Emergency Department

Clinical Pediatric Emergency Medicine

Volumn 8, Issue 2, 2007, Pages 117-122

  Church, Joseph A ^a  

^a CHILDREN S HOSPITAL LOS ANGELES   (United States)

Author keywords

AIDS; emergency department; pediatric HIV

Indexed keywords

ABACAVIR; AMPRENAVIR PHOSPHATE; ANTIBIOTIC AGENT; ANTIRETROVIRUS AGENT; ATAZANAVIR; CD4 ANTIGEN; DELAVIRDINE; DIDANOSINE; EFAVIRENZ; EMTRICITABINE; FAMCICLOVIR; FLUCONAZOLE; HUMAN IMMUNODEFICIENCY VIRUS ANTIBODY; INDINAVIR; ITRACONAZOLE; LAMIVUDINE; LOPINAVIR PLUS RITONAVIR; NELFINAVIR; NEVIRAPINE; PROTEINASE INHIBITOR; RITONAVIR; RNA DIRECTED DNA POLYMERASE INHIBITOR; SAQUINAVIR; STAVUDINE; TENOFOVIR DISOPROXIL; VALACICLOVIR; ZIDOVUDINE;

ABDOMINAL PAIN; ACUTE PANCREATITIS; ADOLESCENT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANEMIA; ANOREXIA; ANTIBODY DETECTION; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BACTERIAL MENINGITIS; BLEEDING; BLOOD TRANSFUSION; BLURRED VISION; CD4+ T LYMPHOCYTE; CHILD; CLINICAL ARTICLE; CONCENTRATION LOSS; CONSULTATION; DIABETES MELLITUS; DIAGNOSTIC TEST; DIARRHEA; DIZZINESS; DRUG EFFICACY; DRUG INDICATION; EMERGENCY CARE; ENZYME IMMUNOASSAY; FATIGUE; FEMALE; FEVER; HEADACHE; HEALTH CARE ACCESS; HEART ARRHYTHMIA; HEPATITIS; HEPATOSPLENOMEGALY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HYPERBILIRUBINEMIA; HYPERGLYCEMIA; HYPERLIPIDEMIA; HYPERSENSITIVITY REACTION; INFANT; INFECTION CONTROL; INSOMNIA; KIDNEY DYSFUNCTION; LACTIC ACIDOSIS; LIVER FUNCTION TEST; LUNG LAVAGE; LYMPHADENOPATHY; LYMPHOCYTE COUNT; MALE; MEDICAL EXPERT; MOUTH LESION; MYALGIA; MYCOBACTERIOSIS; MYCOBACTERIUM INTRACELLULARE AVIUM; NAUSEA; NAUSEA AND VOMITING; NEEDLESTICK INJURY; NEPHROLITHIASIS; NEUTROPENIA; OCCUPATIONAL EXPOSURE; OPPORTUNISTIC INFECTION; PANCREATITIS; PARESTHESIA; PATIENT CARE; PERIPHERAL NEUROPATHY; PNEUMOCYSTIS JIROVECI; PNEUMOCYSTIS PNEUMONIA; POLYMERASE CHAIN REACTION; PR INTERVAL; PROPHYLAXIS; RASH; RESPIRATORY DISTRESS; RISK ASSESSMENT; SEXUAL BEHAVIOR; SIDE EFFECT; SOMNOLENCE; STEATOSIS; STEVENS JOHNSON SYNDROME; TASTE DISORDER; THORAX RADIOGRAPHY; UNPLEASANT DREAM; VOMITING; WEAKNESS;

EID: 34447135650     PISSN: 15228401     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cpem.2007.06.001     Document Type: Article

References (11)

1. Centers for Disease Control and Prevention. Reduction in perinatal transmission of HIV infection-United States, 1985-2005. MMWR 55 (2006) 592-597
2. Center for Disease Control and Prevention. 1994 revised classification system for human immunodeficiency virus infections in children less than 13 years of age. MMWR 43 (1994) 1-10
3. Pantaleo G., Graziosi C., and Fauci A.S. The immunopathogenesis of human immunodeficiency virus infection. N Engl J Med 328 (1993) 327-335
4. Church J.A. Human immunodeficiency infection. In: Osborn L.M., DeWitt F.G., First L.R., and Zenel J.A. (Eds). Pediatrics (2005), Elsevier Mosby, Philadelphia (Pa) 1132-1140
5. Scott G.B., Hutto C., Makuch R.W., et al. Survival in children with perinatally acquired human immunodeficiency virus infection. N Engl J Med 321 (1989) 1791-1796
6. In: Ziechner S.L., and Read J.S. (Eds). Textbook of pediatric HIV care (2005), Cambridge University Press, Cambridge (UK)
7. Wesolowski L.G., Mackellar D.A., Facente S.N., et al. Post-marketing surveillance of OroQuick whole blood and oral fluid rapid HIV testing. AIDS 20 (2006) 1661-1666
8. Lambert J.S., Harris R., Stiehm E.R., et al. Performance characteristics of HIV-1 culture and HIV-1 DNA and RNA amplification assays for the early diagnosis of perinatal HIV-1 infection. J Acquir Immune Defic Syndr 34 (2003) 512-519
9. U.S. Department of Health and Human Services. Pediatric antiretroviral human services: pediatric antiretroviral drug information. Available at:. www.aidsinfo.nih.gov [Accessed 4/4/07]
10. Centers for Disease Control and Prevention. Updated U.S. public health service guidelines for management of occupational exposures to HIV: recommendations for postexposure prophylaxis. MMWR 54 (2005) 1-17
11. Centers for Disease Control and Prevention. Antiretroviral postexposure prophylaxis after sexual injection-drug use, or other nonoccupational exposure to HIV in the United States. MMWR 54 (2005) 1-20